Skip to main content

Advertisement

SpringerLink
Log in

Pediatric multiple sclerosis

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

The diagnosis of multiple sclerosis (MS) in a child remains challenging, given the limited diagnostic criteria and the somewhat poorly defined overlap with acute disseminated encephalomyelitis. Although there are many similarities between pediatric-onset and adult-onset MS, an earlier age at disease presentation seems to be associated with specific features such as more frequent encephalopathy, seizures, and brainstem and cerebellar symptoms during the first event. In addition, the initial brain MRI scan of younger patients shows more frequent involvement of the posterior fossa and higher numbers of ovoid, ill-defined T2-bright foci that often partially resolve on the follow-up scan, thereby challenging early diagnosis. Finally, the spinal fluid in younger patients may fail to reveal oligoclonal bands or elevated IgG index at disease onset.

No therapy for MS in children has been approved by the US Food and Drug Administration. As a result, physicians have started to use off-label drugs approved for adults. Recent data suggest that some children experience a disease breakthrough on first-line therapies approved for adult MS, and thus second-line therapies must be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Krupp LB, Banwell B, Tenembaum S: Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007, 68:S7–S12.

    Article  PubMed  Google Scholar 

  2. Chabas D, Pesic M, McCulloch C, et al.: Pediatric MS onset: a distinct phenotype influenced by ethnicity? [abstract P03.029]. Neurology 2008, 70(Suppl1):A136.

    Google Scholar 

  3. Tenembaum SN, Segura MJ: Presentation, course and outcome of multiple sclerosis in children under 10 years of age [abstract P03.024]. Neurology 2008, 70(Suppl1):A135.

    Google Scholar 

  4. McKeon A, Lennon VA, Lotze T, et al.: CNS aquaporin-4 autoimmunity in children. Neurology 2008, 71:93–100.

    Article  PubMed  CAS  Google Scholar 

  5. Lotze TE, Northrop JL, Hutton GJ, et al.: Spectrum of pediatric neuromyelitis optica. Pediatrics 2008, 122:e1039–e1047.

    Article  PubMed  Google Scholar 

  6. Pittock SJ, Lennon VA, Krecke K, et al.: Brain abnormalities in neuromyelitis optica. Arch Neurol 2006, 63:390–396.

    Article  PubMed  Google Scholar 

  7. Chabas D, Strober J, Waubant E: Pediatric multiple sclerosis. Curr Neurol Neurosci Rep 2008, 8:434–441.

    Article  PubMed  Google Scholar 

  8. Chabas D, McCulloch C, Strober J, et al.: Age modifies MS phenotype at onset [abstract P109]. Mult Scler 2008, 14(suppl):S61.

    Google Scholar 

  9. Duquette P, Murray TJ, Pleines J, et al.: Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr 1987, 111:359–363.

    Article  PubMed  CAS  Google Scholar 

  10. Sindern E, Haas J, Stark E, Wurster U: Early onset MS under the age of 16: clinical and paraclinical features. Acta Neurol Scand 1992, 86:280–284.

    Article  PubMed  CAS  Google Scholar 

  11. Pinhas-Hamiel O, Barak Y, Siev-Ner I, Achiron A: Juvenile multiple sclerosis: clinical features and prognostic characteristics. J Pediatr 1998, 132:735–737.

    Article  PubMed  CAS  Google Scholar 

  12. Ruggieri M, Polizzi A, Pavone L, Grimaldi LM: Multiple sclerosis in children under 6 years of age. Neurology 1999, 53:478–484.

    PubMed  CAS  Google Scholar 

  13. Ghezzi A, Ruggieri M, Trojano M, Filippi M: Italian studies on early-onset multiple sclerosis: the present and the future. Neurol Sci 2004, 25(Suppl 4):S346–S349.

    Article  PubMed  Google Scholar 

  14. Ghassemi R, Antel SB, Narayanan S, et al.: Lesion distribution in children with clinically isolated syndromes. Ann Neurol 2008, 63:401–405.

    Article  PubMed  Google Scholar 

  15. Waubant E, Chabas D, Okuda DT, et al.: Pediatric patients have a higher disease burden and activity on brain MRI at time of MS onset than adults. Arch Neurol 2009 (in press).

  16. Confavreux C, Vukusic S, Adeleine P: Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003, 126:770–782.

    Article  PubMed  Google Scholar 

  17. Mowry EM, Gajofatto A, Blasco MR, et al.: Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children [abstract P03.026]. Neurology 2008, 70(Suppl1):A135.

    Google Scholar 

  18. Nash K, Teasdale S, Chabas D, et al.: Evidence for axonal loss and prominent color vision deficits in children with multiple sclerosis or clinically isolated syndrome [Poster 05.160]. Presented at the 61st Annual Meeting of the American Academy of Neurology. Seattle, WA; April 25–May 2, 2009.

  19. Chabas D, Castillo-Trivino T, Mowry EM, et al.: Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype? Neurology 2008, 71:1090–1093.

    Article  PubMed  CAS  Google Scholar 

  20. McDonald WI, Compston A, Edan G, et al.: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121–127.

    Article  PubMed  CAS  Google Scholar 

  21. Neuteboom RF, Boon M, Catsman Berrevoets CE, et al.: Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008, 71:967–973.

    Article  PubMed  CAS  Google Scholar 

  22. Hahn CD, Shroff MM, Blaser SI, Banwell BL: MRI criteria for multiple sclerosis: evaluation in a pediatric cohort. Neurology 2004, 62:806–808.

    PubMed  Google Scholar 

  23. Callen DJ, Shroff MM, Branson HM, et al.: MRI in the diagnosis of pediatric multiple sclerosis. Neurology 2008 Nov 26 (Epub ahead of print).

  24. Callen DJ, Shroff MM, Branson HM, et al.: Role of MRI in the differentiation of ADEM from MS in children. Neurology 2008 Nov 26 (Epub ahead of print).

  25. Atzori M, Battistella P, Perini P, et al.: Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. Mult Scler 2009, 15:363–370.

    Article  PubMed  CAS  Google Scholar 

  26. Pohl D, Rostasy K, Reiber H, Hanefeld F: CSF characteristics in early-onset multiple sclerosis. Neurology 2004, 63:1966–1967.

    PubMed  CAS  Google Scholar 

  27. Chabas D, Ness J, Yeh A, et al.: Pediatric MS before puberty: a distinct CSF inflammatory profile [S01.003]. Presented at the 61st Annual Meeting of the American Academy of Neurology. Seattle, WA; April 25–May 2, 2009.

  28. Renoux C, Vukusic S, Mikaeloff Y, et al.: Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007, 356:2603–2613.

    Article  PubMed  CAS  Google Scholar 

  29. Banwell B, Krupp L, Kennedy J, et al.: Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 2007, 6:773–781.

    Article  PubMed  Google Scholar 

  30. Trojano M, Paolicelli D, Bellacosa A, et al.: Atypical forms of multiple sclerosis or different phases of a same disease? Neurol Sci 2004, 25(Suppl 4):S323–S325.

    Article  PubMed  Google Scholar 

  31. Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T: Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009, 66:54–59.

    Article  PubMed  Google Scholar 

  32. Ness J, US Pediatric MS Network: Epilepsy in pediatric demyelinating diseases [abstract]. Presented at the 61st Annual Meeting of the American Academy of Neurology. Seattle, WA; April 25–May 2, 2009.

  33. Boiko A, Vorobeychik G, Paty D, et al.: Early onset multiple sclerosis: a longitudinal study. Neurology 2002, 59:1006–1010.

    Article  PubMed  CAS  Google Scholar 

  34. Simone IL, Carrara D, Tortorella C, et al.: Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002, 59:1922–1928.

    PubMed  CAS  Google Scholar 

  35. Julian LJ, Im-Wang S, Chabas D, et al.: Learning and memory in pediatric multiple sclerosis [abstract P780]. Mult Scler 2008, 14(Suppl):S258.

    Google Scholar 

  36. MacAllister WS, Christodoulou C, Milazzo M, Krupp LB: Longitudinal neuropsychological assessment in pediatric multiple sclerosis. Dev Neuropsychol 2007, 32:625–644.

    PubMed  Google Scholar 

  37. Sub Committee of the National MS Society Pediatric MS Network: Pediatric Multiple Sclerosis: Developing Innovative Resources for an Underserved Population. Presented at the 43rd Annual Meeting and Conference of the Society for Social Work Leadership in Health Care. Montreal, Canada; April 2–5, 2008.

  38. Mowry EM, Julian LJ, Chabas D, et al.: Health-related quality of life is reduced in children with multiple sclerosis [abstract P402]. Mult Scler 2008, 14(Suppl):S147.

    Google Scholar 

  39. Waubant E, The US Network of Pediatric MS Centers, Mowry E, James J: Remote EBV, CMV, and HSV-1 and -2 infection status in children with pediatric-onset MS and age-matched healthy controls [abstract]. Mult Scler 2009, 15(Suppl) (in press).

  40. James J, Anderson J, Chabas D, et al.: Pediatric-onset multiple sclerosis patient sera recognize unique regions of Epstein-Barr nuclear antigen 1 compared to matched controls [abstract]. Mult Scler 2009, 15(Suppl) (in press).

  41. Mikaeloff, Y, Caridade G, Assi S, et al.: Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 2007, 130:1105–1110.

    Article  PubMed  Google Scholar 

  42. Mikaeloff Y, Caridade G, Suissa S, Tardieu M: Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2008 Oct 8 (Epub ahead of print).

  43. Mikaeloff, Y, Caridade G, Tardieu M, et al.: Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 2007, 130:2589–2595.

    Article  PubMed  Google Scholar 

  44. Waubant E, Chabas D, Strober J, et al.: 25(OH) Vitamin D levels in children with pediatric-onset MS and controls [abstract]. Mult Scler 2009, 15(Suppl) (in press).

  45. Weinstock-Guttman B, Jacobs LD, Brownscheidle CM, et al.: Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium. Mult Scler 2003, 9:293–298.

    Article  PubMed  CAS  Google Scholar 

  46. Cree BA, Khan O, Bourdette D, et al.: Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004, 63:2039–2045.

    PubMed  CAS  Google Scholar 

  47. Ness J, Middleton S, Harris Y, et al.: Increased African-American representation in a pediatric multiple sclerosis cohort. Presented at 2007 Child Neurology Society Meeting, Montreal, Canada; October 10–13, 2007.

  48. Boster AL, Endress CF, Hreha SA, et al.: Pediatric-onset multiple sclerosis in African-American black and Europeanorigin white patients. Pediatr Neurol 2009, 40:31–33.

    Article  PubMed  Google Scholar 

  49. Krupp L, McLinskey N, Troell R, et al.: Racial and ethnic findings in pediatric MS: an update [abstract]. Neurology 2008, 70(Suppl1):A135.

    Google Scholar 

  50. Boiko AN, Gusev EI, Sudomoina MA, et al.: Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology 2002, 58:658–660.

    PubMed  CAS  Google Scholar 

  51. Waubant E, The US Network of Pediatric MS Centers, Mowry E, et al.: Remote EBV, CMV, and HSV-1 and -2 infection and DRB1*1501/1503 status in children with pediatric-onset MS [abstract]. Mult Scler 2009, 15(Suppl) (in press).

  52. Oksenberg JR, Barcellos LF, Cree BA, et al.: Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004, 74:160–167.

    Article  PubMed  CAS  Google Scholar 

  53. De Jager PL, Simon KC, Munger KL, et al.: Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 2008, 70:1113–1118.

    Article  PubMed  Google Scholar 

  54. Banwell B, Bar-Or A, Cheung R, et al.: Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes. Ann Neurol 2008, 63:98–111.

    Article  PubMed  Google Scholar 

  55. Pohl D, Waubant E, Banwell B, et al.: Treatment of pediatric multiple sclerosis and variants. Neurology 2007, 68(16 Suppl 2):S54–S65.

    Article  PubMed  CAS  Google Scholar 

  56. Ness J, Chabas D, Waubant E, et al.: Use of plasmapheresis in pediatric demyelinating disease [P08.020]. Presented at the 61st Annual Meeting of the American Academy of Neurology. Seattle, WA; April 25–May 2, 2009.

  57. Yeh E, Ness J, Chabas D, et al.: Breakthrough disease in pediatric MS patients: a pediatric network experience [S50.006]. Presented at the 61st Annual Meeting of the American Academy of Neurology. Seattle, WA; April 25–May 2, 2009.

Download references

Author information

Authors and Affiliations

  1. Regional Pediatric Multiple Sclerosis Center, University of California San Francisco, 350 Parnassus Avenue, Suite 908, San Francisco, CA, 94117, USA

    Emmanuelle Waubant

Authors
  1. Emmanuelle Waubant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorothee Chabas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emmanuelle Waubant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waubant, E., Chabas, D. Pediatric multiple sclerosis. Curr Treat Options Neurol 11, 203–210 (2009). https://doi.org/10.1007/s11940-009-0024-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-009-0024-6

Keywords

Search

Navigation